MediBroxol 15 mg / 2 mL

Indication

MediBroxol Injection is indicated for acute and chronic respiratory diseases caused by respiratory mucous secretion disorders, including chronic bronchitis, asthmatic bronchitis, and acute seizures of bronchial asthma. It is also indicated for respiratory distress syndrome in premature infants and neonates, and for the prevention and treatment of preoperative and postoperative pulmonary complications.

Ingredients

• Ambroxol Hydrochloride 15 mg

Direction

Administer intramuscularly (I.M.) or intravenously (I.V.) as directed by a physician. Dosage and route should be determined by a healthcare provider based on patient condition. Refer to package insert for full dosing information.

Side effects

• May cause nausea
• vomiting
• diarrhea
• or allergic reactions. Serious hypersensitivity reactions have been reported rarely. Stop use and seek medical attention if severe reactions occur.

Precautions

• Do not exceed the stated doses. Keep out of reach of children. For use under medical supervision only. Consult a doctor or pharmacist before use. Store at or below 30°C.